Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley B Pounds

Showing results (31-40 of 63) with videos related to

Pageof 7
Sort By:
Cancer|April 8, 2017
Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumorsMaria J Mastellaro, Ana L Seidinger, Guolian Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid LeukemiaRichard J Marrero, Huiyun Wu, Xueyuan Cao, et al.
Nature|March 9, 2007
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaCharles G Mullighan, Salil Goorha, Ina Radtke, et al.
JAMA Network Open|May 16, 2024
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid LeukemiaJatinder K Lamba, Richard Marrero, Huiyun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor MalignanciesHiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Annals of Human Genetics|May 12, 2015
SVSI: fast and powerful set-valued system identification approach to identifying rare variants in sequencing studies for ordered categorical traitsWenjian Bi, Guolian Kang, Yanlong Zhao, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
Pageof 7

Showing results (31-40 of 63) with videos related to

Sort By:
Pageof 7
Cancer|April 8, 2017
Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumorsMaria J Mastellaro, Ana L Seidinger, Guolian Kang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 30, 2024
Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid LeukemiaRichard J Marrero, Huiyun Wu, Xueyuan Cao, et al.
Nature|March 9, 2007
Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemiaCharles G Mullighan, Salil Goorha, Ina Radtke, et al.
JAMA Network Open|May 16, 2024
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid LeukemiaJatinder K Lamba, Richard Marrero, Huiyun Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor MalignanciesHiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Annals of Human Genetics|May 12, 2015
SVSI: fast and powerful set-valued system identification approach to identifying rare variants in sequencing studies for ordered categorical traitsWenjian Bi, Guolian Kang, Yanlong Zhao, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 2009
Genomic analysis reveals few genetic alterations in pediatric acute myeloid leukemiaIna Radtke, Charles G Mullighan, Masami Ishii, et al.
The Lancet. Oncology|March 15, 2020
Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation studySeth E Karol, Thomas B Alexander, Amit Budhraja, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
Pageof 7